title: The haemolytic uraemic syndrome of childhood: is living in Belgium a factor of good prognosis?
authors.forename: C
authors.initials: C
authors.lastname: Vermylen
authors.forename: E
authors.initials: E
authors.lastname: Bodart
authors.forename: J
authors.initials: J
authors.lastname: Ninane
authors.forename: D
authors.initials: D
authors.lastname: Moulin
authors.forename: G
authors.initials: G
authors.lastname: Cornu
mesh_terms: D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D006463:Hemolytic-Uremic Syndrome / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007677:Kidney Function Tests; D010949:Plasma; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011379:Prognosis
chemical_list: D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors